In the last trading session, 49.56 million Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares changed hands as the company’s beta touched 0.63. With the company’s per share price at $2.50 changed hands at $0.77 or 44.77% during last session, the market valuation stood at $4.14M. GLMD’s last price was a discount, traded about -852.0% off its 52-week high of $23.80. The share price had its 52-week low at $1.67, which suggests the last value was 33.2% up since then. When we look at Galmed Pharmaceuticals Ltd’s average trading volume, we note the 10-day average is 5.0 million shares, with the 3-month average coming to 32.65K.
Analysts gave the Galmed Pharmaceuticals Ltd (GLMD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended GLMD as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight. Galmed Pharmaceuticals Ltd’s EPS for the current quarter is expected to be 0.
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) trade information
Instantly GLMD was in green as seen at the end of in last trading. With action 31.93%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -21.63%, with the 5-day performance at 31.93% in the green. However, in the 30-day time frame, Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) is -0.79% down. Looking at the short shares, we see there were 4859.0 shares sold at short interest cover period of 0.26 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 21.08%.
GLMD Dividends
Galmed Pharmaceuticals Ltd is expected to release its next quarterly earnings report on 2024-Apr-03.
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.89% of Galmed Pharmaceuticals Ltd shares while 3.08% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.14%.
